Dr Prafulla Kumar Mishra, Dr Tapan Kumar Mohapatra


Background: Diabetes mellitus is a group of metabolic disease characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. Diabetes mellitus is a common disorder of glucose homeostasis which grows epidemically. Methods: Randomly selected, 45 patients with type-2 diabetic patients with an age ranged from 30 to 65 years along with 45 healthy controls were recruited from the  General Medicine Department. Results: A significant positive correlation was observed between serum ADA with HbA1c, FBS, PPBS, TC and TG in cases compared to controls with P value <0.001 and r value 0.65, 0.20, 0.24, 0.29 and 0.31 respectively. Conclusion: Significantly higher values of ADA in cases compared to controls suggest that ADA plays a role in the pathophysiology of type 2 DM. A positive significantly correlation between serum ADA levels and glycemic parameters


Type 2 DM, Hyperglycemia and Adenosine deaminase(ADA)

Full Text:



Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Medical Journal 2012;27:269-273.

“Diabetes can be controlled in 80 percent of Cases in India”. IANS. news. biharprabha.com. Retrieved 6 February 2014.

Mehta SR, Kashyap CA, Das CS. Diabetes mellitus in India: The Modern Scourge. MJAFI 2009;65:50-54.

Frankie B, Abbas E. Activated T-lymphocytes in type2 diabetes: Implications from in vitro studies. Curr Drug Targets 2003; 4: 493-503.

Vader Weyden MB, Kelly WN. Human adenosine deaminase: distribution and properties. J Biol Chem 1976; 251: 5448-56.

Baghanha MF, Pego A, Lima MA et al. Serum and pleural adenosine deaminase correlation with lymphocyte populations. Chest 1990; 87: 605-10.

Hovi T, Smyth JF, Allison AC, Williams SC. Role of adenosine deaminase in lymphocyte proliferation. Clin Exp Immunol 1976; 23: 395-403.

Sullivan JL, Oxborne WRA, Wedgewood RJ. Adenosine deaminase activity in lymphocytes. Br J Haematol 1977; 37: 157-8.

Kurtul N, Pence S, Akarsu E et al. Adenosine deaminase activity in the serum of type 2 diabetic patients. Acta Medica (Hradec Kralove) 2004; 47 (1): 33-5.

Hoshino T, Yamada K, Masuoka K et al. Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus. Diabetes Res Clin Pract 1994; 25: 97-102.

Kurtul N, Pence S, Akarsu E et al. Adenosine deaminase activity in the serum of type 2 diabetic patients. Acta Medica (Hradec Kralove) 2004; 47 (1): 33-5.

Bergmayer H.V. – “Methods of Enzymatic Analysis”,A.P., N.Y. 1974, Page 1196.

Gabby, K H et al. – J. Clin. End. Met. 44:859,1977.

Richmond W. – Preparation and properties of cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem. 19: 1350-1356, 1973.

Foosati P. and Prencipe L. – Serum triglyceride determined colorimetrically with an enzyme that produce hydrogen peroxide. Clin Chem. 28: 2077-2080, 1982.

Rifai N. and Warnick G.R., Ed.- Laboratory measurements of lipids, lipoproteins and apolipoproteins. AACC press, Washington, DC, USA 1994.

Burtis, C.A. and Ashwood, E.R. Ed. – Tietz Textbook of clinical chemistry, 2nd Ed, Saunders, Philadelphia, 1994.

Friedewald W.T., Levy R.I., Fredrickson D.S., clin Chem. 18:499, 1972.

Giusti G. Adenosine deaminase. In :H.U. Bergmeyer (ed), Methods of enzymatic analysis, Verlag chemie, Weinheim and Academic Press, 2nd edition. New York. 1974:1092-9.

Spencer N, Hopkinson DA, Harris H. Adenosine deaminase polymorphism in man. Annals of Human Genetics. 1968;32(1):9-14.

Shiva Prakash M, Chennaiah S, Murthy YSR. Altered Adenosine Deaminase activity in type 2 Diabetes Mellitus. JICAM. 2006;7:114-7.

Gitangali G, Neerja. The effect of Hyperglycemia on some Biochemical parameters in Diabetes Mellitus. JCDR. 2010;4:3181-6.

Erkilic K, Evereklioglu C, Cekmen M. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, SOD, and GSH in patients Behcet’s Disease. Original contributions/ clinical and laboratory investigations. Mediators Infamm. 2003;12:107-16.

Lee JG, Kang DG, Yu JR, Kim Y, Kim J, Koh G, et al. Changes in adenosine deaminase activity in patients with type 2 diabetes mellitus and effect of DPP-4 inhibitor treatment on ADA activity. Diabetes and Metabolism Journal. 2011;35(2):149-58.

Warrier AC, Rao NY, Mishra TK, Kulpati DS, Mishra KT, Kabi BC. Evaluation of Adenosine Deaminase activity and lipid peroxidation levels in Diabetes Mellitus. Indian Journal of Clinical Biochemistry. 1995;10(1):9-13.

Fovenyi J, Totpal K, Thaisz E, Garam T. Non-specific cellular immunity in type I and type II diabetes. Exp Clin Endocrinol 1984; 83: 203-6.

Paul IT, Vilma D Mottironi, Eugene V Barnett. Cytotoxins in disease: Autocytotoxins in lupus. N Eng J Med 1970; 283: 724-8.

Pettersson T, Ojala K, Weber TH. Adenosine deaminase in the diagnosis of pleural effusions. Act Med Scand 1984; 215: 299-304.

Ungerer JPG, Oustuizen HM, Bissbort SH, Vermaak WJH. Serum adenosine deaminase: isoenzyme and diagnostic applications. Clin Chem 1992; 38: 1322-6.

Giblett ER, Anderson JE, Cohen F et al. Adenosine deaminase deficiency in two patients with impaired cellular immunity. Lancet 1972; 2: 1067-9.

Meuwissen HJ, Pollara B, Pickering RJ. Combined Immunodeficiency disease associate with adenosine deaminase deficiency. J Pediatr 1975; 86: 169-81.

Koehler LH, Benz EJ. Serum adenosine deaminase: methodology and applications. Clin Chem 1962; 8: 133-40.

Goldberg DM. Serum adenosine deaminase in the differential diagnosis of jaundice. Br Med J 1965; 1: 353-5.

Grever MR, Coleman MS, Balcerzak SP. Adenosine deaminase and terminal deoxynucleotidyl transferase: biochemical markers in the management of chronic myelogenous leukemia. Cancer Res 1983; 43:1442-5.

Mishra OP, Garg R, Ali Z , Usha. Adenosine deaminase activity in nephrotic syndrome. J Trop Pediatr 1997; 43: 33-7.

Kavitha K, Yashoda Devi P, Shiva Prakash M. Adenosine deaminase in cord blood as an immunoenzyme marker in low birth weight neonates. Ind J Med Sci 2000; 54: 92-4.

Surekha Rani H, Dayasagar Rao V, Shiva Prakash M. Serum adenosine deaminase activity and C-reactive protein levels in unstable angina. Indian J Hum Genet 2003; 9: 17-20.


  • There are currently no refbacks.